Abiopharma

News list

Patel Naimish 🟢 acquired 1.5K shares of CRISPR Therapeutics AG (CRSP) at $32.96 Transaction Date: Apr 03, 2025 | Filing ID: 024955

Full text

News bot Jan. 29, 2026, 2:16 p.m.
🔍 Patel Naimish (Executive)

Company: CRISPR Therapeutics AG (CRSP)

Report Date: 2025-04-03
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 1,508
Detailed Transactions and Holdings:
- Acquired 1,508 shares of Common Shares at $32.96 per share (Direct)
  Date: 2025-04-03 | Code: P | equity_swap_involved: false | shares_owned_after: 1,508.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The purchase of Common Shares reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 1,508 shares, with a subsequent sale of Common Shares at a price of $35.94 per share on May 29, 2025 pursuant to a mandatory "sell to cover" provision in an award agreement covering a restricted stock unit that vested on such date (and which was reported on a separate Form 4 filing dated May 30, 2025). The Reporting Person has agreed to pay to the Issuer $4,493.84, representing the full amount of the profit realized in connection with the short-swing transaction.